𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The fate of transplanted xenogeneic bone marrow-derived stem cells in rat intervertebral discs

✍ Scribed by Aiqun Wei; Helen Tao; Sylvia A. Chung; Helena Brisby; David D. Ma; Ashish D. Diwan


Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
371 KB
Volume
27
Category
Article
ISSN
0736-0266

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Intervertebral disc degeneration is a major cause and a risk factor for chronic low back pain. The potential of using stem cells to treat disc degeneration has been raised. The aims of our study were to assess whether xenogeneic bone‐marrow derived stem cells could survive in a rat disc degeneration model and to determine which cell types, if any, survived and differentiated into disc‐like cells. Human bone‐marrow derived CD34^+^ (hematopoietic progenitor cells) and CD34^−^ (nonhematopoietic progenitor cells, including mesenchymal stem cells) cells were isolated, fluorescent‐labeled, and injected into rat coccygeal discs. The rats were sacrificed at day 1, 10, 21, and 42. Treated discs were examined by histological and immunostaining techniques and compared to control discs. The survival of transplanted cells was further confirmed with a human nuclear specific marker. Fluorescent labeled CD34^−^ cells were detected until day 42 in the nucleus pulposus of the injected discs. After 3 weeks these cells had differentiated into cells expressing chondrocytic phenotype (Collagen II and Sox‐9). In contrast, the fluorescent labeled CD34^+^ cells could not be detected after day 21. No fluorescence‐positive cells were detected in the noninjected control discs. Further, no inflammatory cells infiltrated the nucleus pulposus, even though these animals had not received immunosuppressive treatment. Our data provide evidence that transplanted human BM CD34^−^ cells survived and differentiated within the relative immune privileged nucleus pulposus of intervertebral disc degeneration. © 2008 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 27:374–379, 2009


📜 SIMILAR VOLUMES


In utero transplantation of human bone m
✍ Shiu-Huey Chou; Tom K. Kuo; Ming Liu; Oscar K. Lee 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 449 KB 👁 1 views

## Abstract Mesenchymal stem cells (MSCs) are multipotent cells that can be isolated from human bone marrow and possess the potential to differentiate into progenies of embryonic mesoderm. However, current evidence is based predominantly on in vitro experiments. We used a murine model of in utero t

Glial cell line-derived neurotrophic fac
✍ Aleksandra Glavaski-Joksimovic; Tamas Virag; Thomas A. Mangatu; Michael McGrogan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 456 KB

## Abstract Parkinson's disease (PD) is a neurodegenerative disease characterized by progressive degeneration of nigrostriatal dopaminergic (DA) neurons. The therapeutic potential of glial cell line‐derived neurotrophic factor (GDNF), the most potent neurotrophic factor for DA neurons, has been dem

Generation of dopamine neurons from embr
✍ Aki Shintani; Naoyuki Nakao; Koji Kakishita; Toru Itakura 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB

## Abstract Stromal cell lines such as PA6 and MS5 have been employed for generating dopamine (DA) neurons from embryonic stem (ES) cells. The present study was designed to test whether bone marrow stromal cells (BMSC) derived from adult mice might be available as a feeder layer to produce DA cells